Published in Pediatr Cardiol on May 14, 2014
The influence of deficient retro-aortic rim on technical success and early adverse events following device closure of secundum atrial septal defects: An Analysis of the IMPACT Registry(®). Catheter Cardiovasc Interv (2016) 1.48
Cost comparison of transcatheter and operative closures of ostium secundum atrial septal defects. Am Heart J (2015) 0.84
Accuracy of Transthoracic Echocardiography in Assessing Retro-aortic Rim prior to Device Closure of Atrial Septal Defects. Congenit Heart Dis (2014) 0.84
Comparison between transcatheter and surgical closure of secundum atrial septal defect in children and adults: results of a multicenter nonrandomized trial. J Am Coll Cardiol (2002) 6.01
Early and late complications associated with transcatheter occlusion of secundum atrial septal defect. J Am Coll Cardiol (2002) 5.41
Inappropriate use of bivariable analysis to screen risk factors for use in multivariable analysis. J Clin Epidemiol (1996) 4.02
Secundum atrial septal defect. Nonoperative closure during cardiac catheterization. JAMA (1976) 3.82
Embolization and retrieval of the Amplatzer septal occluder. Catheter Cardiovasc Interv (2004) 3.13
Erosion of Amplatzer septal occluder device after closure of secundum atrial septal defects: review of registry of complications and recommendations to minimize future risk. Catheter Cardiovasc Interv (2004) 3.08
Transcatheter closure of secundum atrial septal defects. Catheter Cardiovasc Interv (2006) 2.33
Analysis of the US Food and Drug Administration Manufacturer and User Facility Device Experience database for adverse events involving Amplatzer septal occluder devices and comparison with the Society of Thoracic Surgery congenital cardiac surgery database. J Thorac Cardiovasc Surg (2009) 2.17
Echocardiographic predictors of cardiac erosion after Amplatzer septal occluder placement. Catheter Cardiovasc Interv (2013) 1.78
Treatment of isolated secundum atrial septal defects: impact of age and defect morphology in 1,013 consecutive patients. Am Heart J (2008) 1.58
Percutaneous versus surgical closure of secundum atrial septal defects: a systematic review and meta-analysis of currently available clinical evidence. EuroIntervention (2011) 1.40
Incidence of aortic valve regurgitation and outcome after percutaneous closure of atrial septal defects and patent foramen ovale. Heart (2007) 1.09
Short- and intermediate-term results of transcatheter closure of atrial septal defect with the Amplatzer Septal Occluder. Am Heart J (2004) 1.07
Erosions, erosions, and erosions! Device closure of atrial septal defects: how safe is safe? Catheter Cardiovasc Interv (2012) 1.05
Major complications associated with transcatheter atrial septal occluder implantation: a review of the medical literature and the manufacturer and user facility device experience (MAUDE) database. Congenit Heart Dis (2008) 0.97
Long-term (5- to 20-year) outcomes after transcatheter or surgical treatment of hemodynamically significant isolated secundum atrial septal defect. Am J Cardiol (2012) 0.96
Analysis of factors related to successful transcatheter closure of secundum atrial septal defects using the HELEX septal occluder. Am Heart J (2006) 0.94
Single-center experience with the HELEX septal occluder for closure of atrial septal defects in children. J Interv Cardiol (2003) 0.92
Percutaneous atrial septal defect closure in infants and toddlers: predictors of success. Pediatr Cardiol (2012) 0.92
Recent changes in instructions for use for the Amplatzer atrial septal defect occluder: how to incorporate these changes while using transesophageal echocardiography or intracardiac echocardiography? Pediatr Cardiol (2012) 0.86
Impact of occluder device type on success of percutaneous closure of atrial septal defects--a medium-term follow-up study. J Interv Cardiol (2009) 0.83
Continued controversy regarding adverse events after Amplatzer septal device closure: mass hysteria or tip of the iceberg? J Thorac Cardiovasc Surg (2011) 0.79
Negative mucosal synergy between Herpes simplex type 2 and HIV in the female genital tract. AIDS (2007) 3.14
Hepatitis C virus treatment for prevention among people who inject drugs: Modeling treatment scale-up in the age of direct-acting antivirals. Hepatology (2013) 2.76
18 years of the Fontan operation at a single institution: results from 771 consecutive patients. J Am Coll Cardiol (2012) 2.24
Hypoplastic left heart syndrome with atrial level restriction in the era of prenatal diagnosis. Ann Thorac Surg (2007) 2.10
Preoperative brain injury in transposition of the great arteries is associated with oxygenation and time to surgery, not balloon atrial septostomy. Circulation (2009) 1.99
Modeling the current and future disease burden of hepatitis C among injection drug users in Scotland. Hepatology (2005) 1.91
The critical isthmus sites of ischemic ventricular tachycardia are in zones of tissue heterogeneity, visualized by magnetic resonance imaging. Heart Rhythm (2011) 1.71
Systemic-to-pulmonary collateral flow, as measured by cardiac magnetic resonance imaging, is associated with acute post-Fontan clinical outcomes. Circ Cardiovasc Imaging (2012) 1.69
Excess liver-related morbidity of chronic hepatitis C patients, who achieve a sustained viral response, and are discharged from care. Hepatology (2011) 1.68
Cost-effectiveness of hepatitis C virus antiviral treatment for injection drug user populations. Hepatology (2011) 1.67
The precarious state of the liver after a Fontan operation: summary of a multidisciplinary symposium. Pediatr Cardiol (2012) 1.62
An in vitro comparison of the ability of three commonly used pediatric cardiopulmonary bypass circuits to filter gaseous microemboli. Perfusion (2010) 1.61
Treatment of hepatitis C virus infection among people who are actively injecting drugs: a systematic review and meta-analysis. Clin Infect Dis (2013) 1.61
High-fluence and high-density treatment of perioral rhytides using a new, fractionated 2,790-nm ablative erbium-doped Yttrium Scandium Gallium Garnet Laser. Dermatol Surg (2011) 1.60
Elimination of ischemic mitral regurgitation does not alter long-term left ventricular remodeling in the ovine model. Ann Thorac Surg (2010) 1.57
Influence of alcohol on the progression of hepatitis C virus infection: a meta-analysis. Clin Gastroenterol Hepatol (2005) 1.53
Can antiviral therapy for hepatitis C reduce the prevalence of HCV among injecting drug user populations? A modeling analysis of its prevention utility. J Hepatol (2011) 1.50
Sternal wall pressure comparable to leaning during CPR impacts intrathoracic pressure and haemodynamics in anaesthetized children during cardiac catheterization. Resuscitation (2013) 1.49
Open-cell design stents in congenital heart disease: a comparison of IntraStent vs. Palmaz stents. Catheter Cardiovasc Interv (2002) 1.47
ACC/AHA/AAP recommendations for training in pediatric cardiology. Pediatrics (2005) 1.46
Outcomes of Single-Ventricle Patients Supported With Extracorporeal Membrane Oxygenation. Pediatr Crit Care Med (2016) 1.42
Comparison of surgical, stent, and balloon angioplasty treatment of native coarctation of the aorta: an observational study by the CCISC (Congenital Cardiovascular Interventional Study Consortium). J Am Coll Cardiol (2011) 1.39
Combination interventions to prevent HCV transmission among people who inject drugs: modeling the impact of antiviral treatment, needle and syringe programs, and opiate substitution therapy. Clin Infect Dis (2013) 1.38
A multistep approach to improving biopsy site identification in dermatology: physician, staff, and patient roles based on a Delphi consensus. JAMA Dermatol (2014) 1.37
Cardiovascular abnormalities, interventions, and long-term outcomes in infantile Williams syndrome. J Pediatr (2009) 1.36
Noninvasive quantification of systemic-to-pulmonary collateral flow: a major source of inefficiency in patients with superior cavopulmonary connections. Circ Cardiovasc Imaging (2009) 1.32
Long-term outcomes of patients with cardiovascular abnormalities and williams syndrome. Am J Cardiol (2010) 1.30
Are needle and syringe programmes associated with a reduction in HIV transmission among people who inject drugs: a systematic review and meta-analysis. Int J Epidemiol (2013) 1.23
Portal and sinusoidal fibrosis are common on liver biopsy after Fontan surgery. Pediatr Cardiol (2012) 1.18
Association of self-reported alcohol use and hospitalization for an alcohol-related cause in Scotland: a record-linkage study of 23,183 individuals. Addiction (2009) 1.18
Controversies, genetics, diagnostic assessment, and outcomes relating to the heterotaxy syndrome. Cardiol Young (2007) 1.18
Nd:YAG laser (1064 nm) irradiation for lower extremity telangiectases and small reticular veins: efficacy as measured by vessel color and size. Dermatol Surg (2002) 1.17
X-ray magnetic resonance fusion to internal markers and utility in congenital heart disease catheterization. Circ Cardiovasc Imaging (2011) 1.17
Bacterial vaginosis in HIV-infected women induces reversible alterations in the cervical immune environment. J Acquir Immune Defic Syndr (2008) 1.16
Expansion of HIV-specific CD4+ and CD8+ T cells by dendritic cells transfected with mRNA encoding cytoplasm- or lysosome-targeted Nef. Blood (2005) 1.16
Use of angiographic CT imaging in the cardiac catheterization laboratory for congenital heart disease. JACC Cardiovasc Imaging (2010) 1.14
Transcatheter treatment for systemic-to-pulmonary artery shunt obstruction in infants and children. Catheter Cardiovasc Interv (2008) 1.11
Transcatheter device closure of congenital and postoperative residual ventricular septal defects. Circulation (2004) 1.11
Coinfection with herpes simplex virus type 2 is associated with reduced HIV-specific T cell responses and systemic immune activation. J Infect Dis (2008) 1.11
Intervention for recoarctation in the single ventricle reconstruction trial: incidence, risk, and outcomes. Circulation (2013) 1.10
A review of laser and photodynamic therapy for the treatment of nonmelanoma skin cancer. Dermatol Surg (2004) 1.07
Exercise restriction to prevent sudden death in congenital aortic stenosis: whom are we treating? J Am Coll Cardiol (2010) 1.06
X-ray magnetic resonance fusion modality may reduce radiation exposure and contrast dose in diagnostic cardiac catheterization of congenital heart disease. Catheter Cardiovasc Interv (2014) 1.05
The use of photodynamic therapy in dermatology: results of a consensus conference. J Drugs Dermatol (2006) 1.03
A population-based record linkage study of mortality in hepatitis C-diagnosed persons with or without HIV coinfection in Scotland. Stat Methods Med Res (2008) 1.03
The IMPACT registry: IMproving Pediatric and Adult Congenital Treatments. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu (2010) 1.01
Patient radiation exposure in a modern, large-volume, pediatric cardiac catheterization laboratory. Pediatr Cardiol (2014) 1.00
Radiofrequency in cosmetic dermatology: a review. Dermatol Surg (2012) 1.00
Dermal fillers: complications and informed consent. J Cosmet Laser Ther (2005) 1.00
Platelet-endothelial cell adhesion molecule-1-directed immunotargeting to cardiopulmonary vasculature. J Pharmacol Exp Ther (2002) 1.00
Topical anesthetics for cosmetic and laser dermatology. J Drugs Dermatol (2005) 0.99
Impact of re-coarctation following the Norwood operation on survival in the balloon angioplasty era. J Am Coll Cardiol (2005) 0.99
MRI of lymphatic abnormalities after functional single-ventricle palliation surgery. AJR Am J Roentgenol (2014) 0.99
Failure of the fontan circulation. Heart Fail Clin (2014) 0.99
Mesotherapy for facial skin rejuvenation: a clinical, histologic, and electron microscopic evaluation. Dermatol Surg (2006) 0.98
Clinical, histologic and electron microscopic findings after injection of a calcium hydroxylapatite filler. J Cosmet Laser Ther (2004) 0.98
Extraocular sebaceous carcinoma treated with Mohs micrographic surgery: report of a case and review of literature. Dermatol Surg (2007) 0.97
Association between harm reduction intervention uptake and recent hepatitis C infection among people who inject drugs attending sites that provide sterile injecting equipment in Scotland. Int J Drug Policy (2012) 0.95
Calcium hydroxylapatite filler for facial rejuvenation: a histologic and immunohistochemical analysis. Dermatol Surg (2008) 0.95
Detection of hepatitis C virus RNA in dried blood spots. J Clin Virol (2012) 0.94
Surgery for severe ischemic mitral regurgitation. N Engl J Med (2014) 0.94
Decrease in health-related quality of life associated with awareness of hepatitis C virus infection among people who inject drugs in Scotland. J Hepatol (2012) 0.94
Acute effects of embolizing systemic-to-pulmonary arterial collaterals on blood flow in patients with superior cavopulmonary connections: a pilot study. Circ Cardiovasc Interv (2013) 0.93
Drug-related deaths by region, sex, and age group per 100 injecting drug users in Scotland, 2000-01. Lancet (2003) 0.93
Laser lipolysis of the arm, with and without suction aspiration: clinical and histologic changes. J Cosmet Laser Ther (2009) 0.93
Anthrax infection among heroin users in Scotland during 2009-2010: a case-control study by linkage to a national drug treatment database. Clin Infect Dis (2012) 0.93
Infections with spore-forming bacteria in persons who inject drugs, 2000-2009. Emerg Infect Dis (2013) 0.93
Atrophic and a mixed pattern of acne scars improved with a 1320-nm Nd:YAG laser. Dermatol Surg (2003) 0.93
Ultrastructural changes seen after ALA-IPL photorejuvenation: a pilot study. J Cosmet Laser Ther (2005) 0.92
How do centres begin the process to prevent contrast-induced acute kidney injury: a report from a new regional collaborative. BMJ Qual Saf (2011) 0.91
Cardiac magnetic resonance and the need for routine cardiac catheterization in single ventricle patients prior to Fontan: a comparison of 3 groups: pre-Fontan CMR versus cath evaluation. J Am Coll Cardiol (2012) 0.91
Quality metrics in cardiac catheterization for congenital heart disease: utility of 30-day mortality. Catheter Cardiovasc Interv (2014) 0.91
A prospective study of fractional scanned nonsequential carbon dioxide laser resurfacing: a clinical and histopathologic evaluation. Dermatol Surg (2009) 0.90
Clinical, histologic, and ultrastructural changes after use of human growth factor and cytokine skin cream for the treatment of skin rejuvenation. J Cosmet Laser Ther (2008) 0.90
Prevalence and determinants of hepatitis C virus infection among female drug injecting sex workers in Glasgow. Harm Reduct J (2008) 0.90
Complications from injectable polyacrylamide gel, a new nonbiodegradable soft tissue filler. Dermatol Surg (2004) 0.90
Ablative skin resurfacing. Curr Probl Dermatol (2011) 0.90
Clinical comparison of four hair removal lasers and light sources. J Cosmet Laser Ther (2006) 0.90
Safety and efficacy of intradermal injection of botulinum toxin for the treatment of oily skin. Dermatol Surg (2013) 0.89
Guidelines for the outpatient management of complex congenital heart disease. Congenit Heart Dis (2006) 0.89